Target intelligence / Profile preview

Cellular DNA and associated macromolecules (DNA)

Target
DNA
Molecular classification
Nucleic acid, Macromolecule, Chromatin
01

Overview

Cellular DNA and its associated macromolecules, such as histones and the broader chromatin structure, serve as the primary biological targets for ionizing radiation during total body irradiation (TBI). TBI is a medical procedure used primarily as a conditioning regimen for hematopoietic stem cell transplantation to eradicate malignant cells and induce systemic immunosuppression (StatPearls, 2023). The mechanism of action involves the induction of complex DNA damage, including single-strand and double-strand breaks, through both direct ionization and the generation of reactive oxygen species (Hall & Giaccia, 2018). This damage triggers the DNA damage response, leading to cell cycle arrest, senescence, or apoptosis, particularly in rapidly dividing hematopoietic and neoplastic cells (PubMed, 2022). While effective for cytoreduction, the non-specific nature of DNA damage across the entire body presents significant therapeutic challenges, including the risk of acute radiation syndrome and long-term complications like secondary malignancies or organ dysfunction (NIH, 2022). Consequently, TBI is often carefully dosed and sometimes combined with DNA-targeting drugs like cyclophosphamide to optimize the therapeutic index (NCBI, 2020).

Other names
Deoxyribonucleic acidGenomic DNANuclear DNAChromatinTotal body irradiation target
02

Mechanism of action

Ionizing radiation causes DNA damage through direct ionization of the phosphodiester backbone or indirect action via water radiolysis, creating hydroxyl radicals that induce oxidative damage. The resulting double-strand breaks (DSBs) are the primary lethal lesions, activating the ATM/ATR signaling pathways and p53-mediated apoptosis (Hall & Giaccia, 2018; PubMed, 2022).

03

Biological functions

Genetic information storageDNA replicationTranscriptionCell division
04

Disease associations

LeukemiaLymphomaAcute radiation syndromeMyelodysplastic syndromes
05

Safety considerations

Radiation pneumonitisVeno-occlusive disease of the liverSecondary malignanciesCataractsEndocrine dysfunction
06

Interacting drugs

Cyclophosphamide

4 more in the full profile.

07

Biomarkers

gamma-H2AXDicentric chromosome assayMicronucleus assayLymphocyte depletion kinetics

Beyond the preview

Go deeper on Cellular DNA and associated macromolecules (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular DNA and associated macromolecules (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call